Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CFO David Thomas Evans purchased 150,000 shares of the company’s stock in a transaction that occurred on Friday, May 15th. The shares were purchased at an average cost of $0.65 per share, for a total transaction of $97,500.00. Following the completion of the transaction, the chief financial officer directly owned 267,930 shares of the company’s stock, valued at $174,154.50. This represents a 127.19% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website.
David Thomas Evans also recently made the following trade(s):
- On Monday, May 18th, David Thomas Evans purchased 50,000 shares of Cardlytics stock. The shares were purchased at an average cost of $0.63 per share, for a total transaction of $31,500.00.
Cardlytics Price Performance
CDLX opened at $0.60 on Wednesday. The company’s 50-day moving average is $0.87 and its 200 day moving average is $1.05. Cardlytics, Inc. has a fifty-two week low of $0.57 and a fifty-two week high of $3.28. The firm has a market capitalization of $34.34 million, a P/E ratio of -0.34 and a beta of 0.67.
Wall Street Analysts Forecast Growth
CDLX has been the topic of a number of recent analyst reports. Wall Street Zen raised shares of Cardlytics from a “sell” rating to a “hold” rating in a research report on Saturday, April 4th. Bank of America reissued an “underperform” rating on shares of Cardlytics in a research report on Thursday, March 5th. Evercore set a $1.00 price objective on shares of Cardlytics in a research report on Friday, March 6th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Cardlytics in a research report on Friday, April 10th. Finally, Lake Street Capital set a $1.00 price objective on shares of Cardlytics in a research report on Friday, May 8th. One analyst has rated the stock with a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Sell” and a consensus target price of $1.00.
Read Our Latest Stock Analysis on Cardlytics
Institutional Trading of Cardlytics
Several hedge funds have recently added to or reduced their stakes in the stock. Bank of America Corp DE raised its position in Cardlytics by 262.7% in the third quarter. Bank of America Corp DE now owns 1,632,786 shares of the company’s stock worth $3,968,000 after acquiring an additional 1,182,593 shares during the period. Quinn Opportunity Partners LLC increased its stake in shares of Cardlytics by 900.0% in the third quarter. Quinn Opportunity Partners LLC now owns 1,100,000 shares of the company’s stock worth $2,673,000 after purchasing an additional 990,000 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of Cardlytics by 3.3% in the fourth quarter. Geode Capital Management LLC now owns 654,472 shares of the company’s stock worth $753,000 after purchasing an additional 20,908 shares in the last quarter. UBS Group AG increased its stake in shares of Cardlytics by 112.5% in the third quarter. UBS Group AG now owns 458,066 shares of the company’s stock worth $1,113,000 after purchasing an additional 242,536 shares in the last quarter. Finally, Invesco Ltd. increased its stake in shares of Cardlytics by 38.1% in the fourth quarter. Invesco Ltd. now owns 170,122 shares of the company’s stock worth $196,000 after purchasing an additional 46,973 shares in the last quarter. Institutional investors own 68.10% of the company’s stock.
Cardlytics Company Profile
Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.
At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.
Featured Articles
- Five stocks we like better than Cardlytics
- HIVE Weaponizes Power for an AI Pivot
- A Deep Dive Into NVIDIA’s Latest Portfolio Moves
- Brady Corp Wires Up a Massive AI-Powered Breakout
- Why Home Depot’s Sell-Off Could Become a Huge Opportunity
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
